Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$187M |
| 2 |
Amazon
AMZN
|
+$170M |
| 3 |
Analog Devices
ADI
|
+$104M |
| 4 |
Palantir
PLTR
|
+$95.7M |
| 5 |
Tesla
TSLA
|
+$75.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$364M |
| 2 |
Microsoft
MSFT
|
+$269M |
| 3 |
L3Harris
LHX
|
+$185M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$166M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Healthcare | 14.18% |
| 3 | Consumer Discretionary | 13.57% |
| 4 | Communication Services | 11.56% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
MGE Energy Inc
MGEE
$3.06B
| $5.86M | ﹤0.01% |
79,750
| – | – |
|
|
KW
1352
DELISTED
Kennedy-Wilson Holdings
KW
| $5.86M | ﹤0.01% |
279,968
-500
| -0.2% | -$10.4K |
|
1353
Trupanion
TRUP
$1.36B
| $5.84M | ﹤0.01% |
75,210
+1,300
| +2% | +$128K |
|
1354
Visteon
VC
$2.86B
| $5.83M | ﹤0.01% |
61,800
+300
| +0.5% | +$32.4K |
|
1355
CVB Financial
CVBF
$4.08B
| $5.81M | ﹤0.01% |
285,300
+1,400
| +0.5% | +$27.6K |
|
|
MDC
1356
DELISTED
M.D.C. Holdings, Inc.
MDC
| $5.8M | ﹤0.01% |
124,243
+700
| +0.6% | +$35.5K |
|
1357
Cytokinetics
CYTK
$10.2B
| $5.79M | ﹤0.01% |
162,100
+37,300
| +30% | +$1.1M |
|
|
PDCO
1358
DELISTED
Patterson Companies, Inc.
PDCO
| $5.79M | ﹤0.01% |
192,200
+800
| +0.4% | +$24.3K |
|
|
HAPN
1359
Happen Inc
HAPN
$2.27B
| $5.76M | ﹤0.01% |
204,160
+10,500
| +5% | +$260K |
|
|
IBTX
1360
DELISTED
Independent Bank Group, Inc.
IBTX
| $5.76M | ﹤0.01% |
81,122
+300
| +0.4% | +$20.9K |
|
1361
SITE Centers
SITC
$158M
| $5.76M | ﹤0.01% |
478,221
+41,144
| +9% | +$499K |
|
1362
Belden
BDC
$5.36B
| $5.76M | ﹤0.01% |
98,800
+400
| +0.4% | +$21.4K |
|
1363
Boot Barn
BOOT
$4.92B
| $5.74M | ﹤0.01% |
64,600
+700
| +1% | +$60.3K |
|
|
RCM
1364
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.73M | ﹤0.01% |
260,500
+1,500
| +0.6% | +$31K |
|
|
AGNT
1365
AGNT Inc
AGNT
$752M
| $5.73M | ﹤0.01% |
144,000
+5,200
| +4% | +$223K |
|
1366
Comfort Systems
FIX
$60.8B
| $5.72M | ﹤0.01% |
80,200
+400
| +0.5% | +$29.8K |
|
|
SFIX
1367
Stitch Fix
SFIX
$487M
| $5.72M | ﹤0.01% |
143,100
+11,300
| +9% | +$528K |
|
1368
Sunstone Hotel Investors
SHO
$2.02B
| $5.7M | ﹤0.01% |
477,749
+2,500
| +0.5% | +$29.1K |
|
1369
First Majestic Silver
AG
$9.26B
| $5.68M | ﹤0.01% |
504,600
+61,300
| +14% | +$791K |
|
1370
TransAlta
TAC
$3.99B
| $5.68M | ﹤0.01% |
540,800
-5,200
| -1% | -$52.1K |
|
|
ITCI
1371
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.68M | ﹤0.01% |
152,500
+900
| +0.6% | +$31.3K |
|
|
HSKA
1372
DELISTED
Heska Corp
HSKA
| $5.66M | ﹤0.01% |
21,900
+2,100
| +11% | +$535K |
|
1373
Cannae Holdings
CNNE
$675M
| $5.66M | ﹤0.01% |
181,794
| – | – |
|
1374
Agios Pharmaceuticals
AGIO
$2B
| $5.65M | ﹤0.01% |
122,460
-15,600
| -11% | -$754K |
|
1375
Plexus
PLXS
$7.04B
| $5.65M | ﹤0.01% |
63,200
-300
| -0.5% | -$26.7K |
|
Similar funds
Swiss National Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Swiss National Bank held 2,649 positions worth $157B, down 3% from $162B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 1.3%. Swiss National Bank opened 7 new positions and exited 28, leaving the 2,649-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2021 buy was DoorDash: 291,100 shares worth $60M.
- Swiss National Bank added most to Snowflake in Q3 2021, an estimated $187M increase.
- Swiss National Bank's biggest Q3 2021 reduction was Apple, cutting an estimated $364M.
- Swiss National Bank fully exited L3Harris in Q3 2021, selling an estimated $185M.
- Swiss National Bank's ten largest holdings make up 26% of its $157B portfolio in Q3 2021.
- Swiss National Bank opened 7 new positions and closed 28 in Q3 2021.
- Swiss National Bank's portfolio value fell 3% quarter-over-quarter to $157B.
Based on Swiss National Bank's 13F filing for Q3 2021, filed 8 Nov 2021.